Purpose: The purpose of this review is to outline the etiology, clinical features, and management of acute corneal hydrops (CH) in cases of keratoconus (KC).
INTRODUCTION
Acute corneal hydrops (CH) is the development of marked corneal edema caused by a break in the descemet membrane (DM) allowing aqueous to leak into the stroma and epithelium. [1] [2] [3] [4] It is most commonly seen in cases of keratoconus (KC), but has also been reported as a complication of other corneal ectasias like pellucid marginal corneal degeneration (PMCD), keratoglobus and Terrien's marginal degeneration (TMD). 1 The reported incidence ranges from 2.6 to 35%.
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Epidemiology and Risk Factors
Risk factors for CH include young age, male sex, poor visual acuity at presentation, steep keratometry, 2 severe ectasia at presentation, 5 eccentric cone location, 6 co-existent vernal keratoconjunctivitis, 7 down syndrome, 8 congenital rubella, 9 corneal microtrauma due to repeated eye rubbing. Among all associated factors eye rubbing is the most important risk factor.
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Natural History of Corneal Hydrops
Acute hydrops develops when the DM of ectatic cornea splits, allowing the aqueous to seep into the stroma. Often a preceding history of vigorous eye rubbing or coughing is present. 10 The elasticity of DM causes its edges to retract and curl anteriorly, 11 and this is responsible for the delayed resolution of corneal edema associated with hydrops compared to that developing after a DM breach developing during cataract surgery on a keratoconic eye. 12 Continuous seepage of aqueous separates the collagen lamellae and forms large fluid-filled stromal pockets and epithelial bullae. 13 Subsequently, over a period of time ranging from 2 to 4 months, the adjacent endothelial cells enlarge and migrate to cover the defect as a part of reparative process. This seals the defect and prevents further seepage of aqueous leading to resolution of hydrops.
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Clinical Features
The onset of acute hydrops is usually heralded by sudden onset of watering, photophobia, pain and markedly reduced visual acuity. 2 Slit-lamp examination reveals conjunctival hyperemia, epithelial microcystic edema, and marked stromal edema with intervening fluid clefts. Corneal edema can be graded depending upon its extent of involvement with grade 1 as stromal edema limited to a circle of 3 mm diameter, grade 2 as edema between circles of 3 and 5 mm diameters, and grade 3 as edema extending beyond a circle of 5 mm diameter. 13 Although most cases resolve with a scar, complications can occur, such as corneal neovascularization, 2, 16 keratitis, pseudo cyst formation, and corneal perforation. 
Investigations
Investigations help to determine the size and extent of stromal edema and to localize the DM tear which helps to plan the treatment, monitor the esponse of therapy, and identify any complication developing during follow-up. These include ultrasound biomicroscopy (UBM), anterior segment optical coherence tomography (ASOCT) and confocal microscopy.
Ultrasound Biomicroscopy
In acute phase UBM clearly delineates DM tear as an area of deficiency under the site of maximum corneal edema. 12, 13 The characteristic continuous curvilinear and brightly intense spike of an intact DM is absent. It reveals the number (single or multiple), site, size, and communication of intrastromal cysts/clefts and the length of tear.
Anterior Segment Optical Coherence Tomography
Anterior segment optical coherence tomography reveals epithelial and stromal edema, intrastromal fluid clefts and DM detachment. Intrastromal cysts appear as hyporeflective areas within the stromal bed. 17 It helps to document serial corneal thickness measurements and, thereby aids in monitoring the response of treatment. [18] [19] [20] Three patterns of DM appearance have been described during acute hydrops: detachment with break and rolled ends, detachment with break and flat ends, and detachments with no break. 19 
Confocal Microscopy 21
Confocal microscopy helps to demonstrate epithelial as well as stromal edema. It reveals epithelial wing cells as hyper-reflective areas suggestive of fluid influx. The keratocyte densities are lower in the edematous area and have oddly shaped nuclei.
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Management
Most cases of CH resolve spontaneously without intervention over a period of 2 to 4 months. However, increasing duration of corneal edema predisposes to an increased risk of corneal complications, such as neovascularisation, therefore, many therapeutic options employed today aim to facilitate early resolution of hydrops. Treatment regimens can be divided into conservative and surgical options.
Conservative Treatment
Medical therapy primarily aims to provide symptomatic relief till spontaneous resolution occurs. It usually includes topical lubricants, broad spectrum topical antibiotics (to prevent secondary infection), cycloplegics (to reduce pain and photophobia), hyperosmotic agents (to reduce epithelial and intrastromal edema), anti-glaucoma medications (to lessen the hydrodynamic force on posterior corneal surface), and topical steroids or nonsteroidal anti-inflammatory drugs (to reduce inflammation and prevent neovascularization). [1] [2] [3] 22 Topical NSAIDs should be used cautiously as they may lead to stromal thinning or corneal perforation when used at higher doses (>7 drops per day).
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Surgical Therapy
Various surgical modalities employed for CH management are as follows:
• Intracameral air/gas injection Various agents, which have been tried for intra cameral injection include air, 25 20% sulfur hexafluoride (SF 6 ) 26 and 14% perfluoropropane (C 3 F 8 ). 13, 23 The difference among these agents, is the duration of action. Air is the shortest acting agent hence repeated injections are required. 25 Sulfur hexafluoride is longer acting compared to air (stays for around 2 weeks) however, repeat injections may still be required. 26 Perfluoropropane is the longest acting agent and usually repeat injections are not needed. 23 Intracameral air/gas injection acts by following mechanisms; reposits DM to the corneal stroma by bringing its ends close together, acts as a mechanical barrier against further fluid entry 25,26 and facilitates faster healing of endothelial cells over the exposed stroma.
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Surgical Technique
Preoperative pupillary constriction is achieved using topical 2% pilocarpine nitrate to avoid intraoperative injury to the lens. 0.1 ml aqueous humor is aspirated using a 26/27 gauge needle followed by of air/gas injection (20% nonexpansile concentration of SF 6 or 14% nonexpansile concentration of C 3 F 8 ) so as to fill two-third anterior chamber. 25, 26 An alternate technique involves inserting a second empty tuberculin syringe with a 26/27 gauge needle without plunger in an oblique fashion into the anterior chamber from a different site so that the aqueous humor is pushed out through the second syringe when gas in the first tuberculin syringe is injected into the anterior chamber. 13 The latter technique allows smooth unrolling of the curled descemet membrane. A surgical peripheral iridectomy may be performed before injection to avoid papillary block glaucoma. 22 Postoperatively, supine position is advised for 2 weeks along with topical antibiotics, hypertonic saline, steroids and antiglaucoma medications. Repeat injections may be needed in cases with persistent corneal edema. 25, 26 The time of resolution of hydrops following intracameral air/gas injection has been found to be less in various studies 22, 25 although the visual outcome may 26 or may not 22, 25 improve (Table 1) .
Complications
The complications of intracameral air/gas injection include intrastromal gas migration, 27 pupillary block glaucoma, 22 endothelial cell loss, 28 cataract formation, keratitis 25 and Urrets Zavalia syndrome. 29 Intrastromal migration of the gas occurs due to fish egging of gas during the injection procedure, which prevents the closure of the intrastromal cleft and impedes the resolution of hydrops.
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• Compressive sutures with gas injection Application of compressive sutures along with gas injection has been reported to be successful in severe cases with wide separation of edges of descemet membrane and formation of cleft like structures with fistulous communication. Intracameral gases alone may fail to occlude the tear in these cases. Also trapping of gas in the stromal clefts can occur which can delay the resolution of edema 27 and incite inflammation and vascularisation.
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Sutures bring the gaped edges close together and fasten the resolution of edema. Two to five full-thickness sutures with 10-0 nylon are applied across the tear, starting 1 to 2 mm from its edges after injecting the gas. The sutures are removed 2 to 6 weeks later.
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• Tissue adhesives with bandage contact lens (BCL) Rarely in cases of severe acute hydrops a fistula may form. Cyanoacrylate tissue adhesive with BCL (TABCL) may succeed in sealing these small perforations, thereby avoiding emergency tectonic keratoplasty. 32 • Amniotic membrane transplantation (AMT) with cauterization.
In cases with persistent corneal edema, 15 to 32 cautery applications under saline irrigation followed by stromal puncture with a 24-gauge disposable needle at the site of maximal edema and AMT has been reported. 32 Cauterization allows excess water to evaporate from the stroma and AMT helps in reducing inflammation, vascularisation and scarring.
• Keratoplasty
Penetrating keratoplasty is rarely required in cases of acute corneal hydrops. Indications incude persistent corneal edema, 3 corneal perforation, 33 large DM tear, 13, 27 intrastromal cyst formation, 27 and corneal neovascularisation.
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Deep anterior lamellar keratoplasty (DALK) offers less risk of endothelial graft rejection and better longterm graft survival compared to PK, however, it is more technically challenging.
Recently, use of descemet stripping endothelial keratoplasty (DSEK) has been reported in cases of hydrops with keratoglobus and chronic hydrops. However, the same has not been reported in cases of keratoconus.
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CONCLUSION
Acute corneal hydrops may be managed either with medical therapy alone or with surgical intervention. The use of intracameral gases may or may not improve the final BCVA, however, it does reduce the duration of corneal edema, thereby limiting the complications associated with long standing corneal edema like corneal neovascularisation which poses an increased risk of graft rejection and failure should a keratoplasty is performed later. Other treatment modalities, such as compressive sutures, tissue adhesives with bandage contact lens and amniotic membrane transplantation with cryotherapy may be helpful in special situations. 
